 |
市場調查報告書
商品編碼
2058297
寵物癌症治療市場：依治療方法、寵物種類、給藥途徑、應用及地區分類。Pet Cancer Therapeutics Market, By Therapy Type, By Pet Type, By Mode of Administration, By Application, By Geography |
||||||
價格
簡介目錄
2026年寵物癌症治療市場規模估計為117億美元，預計2033年將達到187億美元。預計2026年至2033年，該市場將以8.3%的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 117億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 8.30% | 2033年市場規模預測： | 187億美元 |
寵物癌症治療包括化療藥物、標靶治療、聯合治療和免疫療法疫苗，這些都是獸醫常用的治療方法。這些藥物主要用於治療多種疾病，包括淋巴瘤、肥大細胞瘤、纖維肉瘤和血管肉瘤。目前，全球市面上有多種劑型的寵物癌症治療藥物可供選擇，給藥方式包括片劑、注射劑和外用製劑。因此，有瞭如此豐富的治療方法選擇，寵物可以更方便地獲得最適合其病情控制的有效癌症治療。
市場動態
寵物癌症治療市場成長的主要驅動力是眾多用於治療淋巴瘤和黑色素瘤等高發病的在研藥物。例如，2017年，Aratana Therapeutics公司研發的AT-014疫苗獲得了美國農業部獸醫生技藥品中心的批准，該疫苗是一種用於治療一歲及以上犬類骨癌骨癌的疫苗。該候選藥物由Advacis公司獨家核准，目前正在進行III期臨床試驗。此外，獸醫癌症協會、Petco基金會和動物癌症基金會等私營和政府機構正在合作開發犬貓新藥，預計將成為預測期內寵物癌症治療市場成長的主要驅動力。然而，寵物疾病認知不足、治療費用高昂以及藥物副作用等因素正在限制寵物癌症治療市場的成長。
本次調查的主要特點
- 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
- 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
- 本研究根據以下參數對全球寵物癌症治療市場的主要參與者進行了分析：公司概況、財務表現、產品系列、市場佔有率、分銷策略、關鍵發展和策略以及未來計劃。
- 透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
- 這份全球寵物癌症治療市場報告旨在為行業內的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過利用寵物癌症藥物市場分析中使用的各種策略矩陣來簡化決策過程。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 抑制因子
- 市場機遇
- 主要亮點
- 管道分析
- 監管指南
- 預防寵物癌症的努力
- 已通過核准的寵物癌症標靶治療
- 流行病學
第4章 全球寵物癌症治療市場：依治療類型分類，2021-2033年
- 化療
- 標靶治療
- 聯合治療
- 免疫療法
第5章 全球寵物癌症治療市場：依寵物類型分類，2021-2033年
- 貓
- 狗
- 馬
第6章 全球寵物癌症治療市場：依給藥途徑分類，2021-2033年
- 口服
- 靜脈
- 外用
第7章 全球寵物癌症治療市場：依應用領域分類，2021-2033年
- 淋巴瘤
- 肥大細胞癌
- 黑色素瘤
- 乳癌和鱗狀細胞癌
- 其他
第8章 全球寵物癌症治療市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
- 中東
- GCC
- 以色列
- 其他中東國家
- 非洲
- 南非
- 中非
- 北非
第9章 競爭情勢
- 熱圖分析
- 市佔率分析（3x3矩陣）
- 公司簡介
- Aratana Therapeutics, Inc.
- AB Science
- Boehringer Ingelheim International GmbH
- Zenoaq
- Morphogenesis, Inc.
- VetDC, Inc.
- Karyopharm Therapeutics, Inc.
- Rhizen Pharmaceuticals SA
- Regeneus Ltd.
- Oasmia Pharmaceuticals AB
- Zoetis
第10章
- 參考
- 調查方法
簡介目錄
Product Code: CMI1284
Pet Cancer Therapeutics Market is estimated to be valued at USD 11.7 Bn in 2026 and is expected to reach USD 18.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 11.7 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.30% | 2033 Value Projection: | USD 18.7 Bn |
The pet cancer therapeutics include chemotherapy drugs, targeted therapies, combination therapies, and immunotherapy vaccines, which are commonly recommended by the veterinary doctors. The drugs are mostly recommended to treat various conditions such as lymphoma, mast cell tumors, fibrosarcoma, hemangiosarcoma, and others. Currently, a wide range of formulations are available in the global market for the treatment of pet cancers, which can be administered in the form of tablets, injections or can be applied topically. Thus, the large variety of treatment options has made it easy for the pets to receive effective cancer treatment suitable to curb the condition.
Market Dynamics
The major factor driving growth of the pet cancer therapeutics market include robust number of pipeline drugs for the treatment of highly prevalent conditions such as lymphoma and melanoma. For instance, in 2017, Aratana Therapeutics received approval from the United States Department of Agriculture (USDA) Center for Veterinary Biologics for canine osteosarcoma vaccine- AT-014 for the treatment of dogs diagnosed with osteosarcoma, one year of age or older. The drug candidate was licensed exclusively from Advaxis, Inc. and is currently in the pivotal trial. Moreover, the private and government organizations such as Veterinary Cancer Society, Petco Foundation, and Animal Cancer Foundation are working together to formulate novel drugs for dogs and cats, which is a major factor expected to propel growth of the pet cancer therapeutics market over the forecast period. However, lack of awareness regarding pet diseases, high cost, and adverse effects of the drugs are the factors restraining pet cancer therapeutics market growth.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global pet cancer therapeutics market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Aratana Therapeutics, Inc., AB Science, Boehringer Ingelheim International GmbH, Zenoaq, Morphogenesis, Inc., VetDC, Inc., Karyopharm Therapeutics, Inc., Rhizen Pharmaceuticals SA, Regeneus Ltd., Oasmia Pharmaceuticals AB, and Zoetis
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global pet cancer therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the pet cancer therapeutics market
Market Segmentation
- By Therapy Type: (Revenue, USD Bn, 2021-2033)
- Chemotherapy
- Targeted Therapy
- Combination Therapy
- Immunotherapy
- By Pet Type: (Revenue, USD Bn, 2021-2033)
- Cat
- Dog
- Horse
- By Mode of Administration: (Revenue, USD Bn, 2021-2033)
- Oral
- Intravenous
- Topical
- By Application: (Revenue, USD Bn, 2021-2033)
- Lymphoma
- Mast Cell Cancer
- Melanoma
- Mammary and Squamous Cell Cancer
- Others
- By Region: (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Aratana Therapeutics, Inc.
- AB Science
- Boehinger Ingelheim International GmbH
- Zenoaq
- Morphogenesis, Inc.
- VetDC, Inc.
- Karyopharm Therapeutics, Inc.
- Regeneus Ltd.
- Rhizen Pharmaceuticals SA
- Oasmia Pharmaceuticals AB
- Zoetis
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Therapy Type
- Market Snippet, By Pet Type
- Market Snippet, By Mode of Administration
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Key Highlights
- Pipeline Analysis
- Regulatory Guidelines
- Initiatives for Prevention of Pet Cancer
- Approved Targeted Therapies for Pet Cancer
- Epidemiology
4. Global Pet Cancer Therapeutics Market, By Therapy Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Combination Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Pet Cancer Therapeutics Market, By Pet Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Cat
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Dog
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Horse
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Pet Cancer Therapeutics Market, By Mode of Administration, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Pet Cancer Therapeutics Market, By Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Lymphoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Mast Cell Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Melanoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Mammary and Squamous Cell Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Pet Cancer Therapeutics Market, By Region, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- North America
- Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Pet Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Mode of Administration, 2021-2033, (USD Bn)
- Market Size and Forecast, By Application, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
- South Africa
- Central Africa
- North Africa
9. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis (3x3 Matrix)
- Company Profiles
- Aratana Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- AB Science
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Boehringer Ingelheim International GmbH
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Zenoaq
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Morphogenesis, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- VetDC, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Karyopharm Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Rhizen Pharmaceuticals SA
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Regeneus Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Oasmia Pharmaceuticals AB
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Zoetis
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Analyst Views
- Aratana Therapeutics, Inc.
10. Section
- References
- Research Methodology
- About us and Sales Contact
